A
$ Value
$0
Shares
8,067
Price
$0
Filed
Feb 2
Insider
Name
Cuffe Michael S.
Title
EVP and Chief Clinical Officer
CIK
0001632835
Roles
Officer
Transaction Details
Transaction Date
2026-01-29
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
8,067
Footnotes
The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027.
Filing Info
Cuffe Michael S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | HCA | A | $0 |
| 2026-02-10 | HCA | F | $1.8M |
| 2026-02-03 | HCA | ▼ | $747K |
| 2026-02-03 | HCA | G | $0 |
| 2026-01-29 | HCA | A | $0 |
| 2025-09-08 | HCA | ▼ | $1.6M |
| 2025-09-04 | HCA | M | $1.9M |
| 2025-09-04 | HCA | F | $2.9M |
| 2025-09-04 | HCA | M | $0 |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |